Generation Bio Co. (GBIO)
NASDAQ:GBIO
US Market
Holding GBIO?
Track your performance easily

Generation Bio (GBIO) Financial Statements

134 Followers

Generation Bio Financial Overview

Generation Bio's market cap is currently ―. The company's EPS TTM is $-2.39; its P/E ratio is -0.92; Generation Bio is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 4.09M$ 4.06M$ 2.88M$ 2.15M$ 880.00K
Gross Profit$ 4.09M$ 4.06M$ 2.88M$ 2.15M$ 880.00K
EBIT$ -20.43M$ -74.51M$ -35.19M$ -28.27M$ -31.07M
EBITDA$ -19.17M$ -73.20M$ -33.86M-$ -29.72M
Net Income Common Stockholders$ -20.43M$ -74.50M$ -35.19M$ -28.27M$ -31.07M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 216.94M$ 219.30M$ 264.36M$ 291.02M$ 314.14M
Total Assets$ 265.26M$ 285.88M$ 374.76M$ 381.49M$ 404.88M
Total Debt$ 93.96M$ 95.94M$ 97.89M$ 79.71M$ 80.63M
Net Debt$ -122.98M$ -123.36M$ -166.47M$ -211.31M$ -233.51M
Total Liabilities$ 149.86M$ 153.89M$ 171.63M$ 149.58M$ 150.60M
Stockholders Equity$ 115.36M$ 131.99M$ 203.13M$ 231.91M$ 254.29M
Cash Flow-
Free Cash Flow$ -21.45M$ -33.62M$ -29.56M-$ 23.38M
Operating Cash Flow$ -21.54M$ -31.70M$ -24.98M$ -24.90M$ 24.84M
Investing Cash Flow$ 12.09M$ -553.00K$ -1.91M$ -26.58M$ 24.41M
Financing Cash Flow$ 234.00K$ -125.00K$ 77.00K$ -131.00K$ 99.00K
Currency in USD

Generation Bio Earnings and Revenue History

Generation Bio Debt to Assets

Generation Bio Cash Flow

Generation Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis